how to become ceiv pharma certified - cold …€¦ · how to become ceiv pharma certified ......
TRANSCRIPT
Q1 2015
IATA - CEIV Pharma
1
HOW TO BECOME CEIV PHARMA CERTIFIEDQ1 2015 By: Mazen Al-Homsi
Manager Cargo, Gulf Area & YemenIATA Abu Dhabi Office
2
Content Page
1.0 Introduction: Pharma logistical market growing but air cargo losing market share to other modes of transportation
3
2.0 Objective: CEIV Pharma is a concerted effort to improve the level of competency, operational and technical preparedness
15
3.0 Approach and methodology: Validate knowledge, facilities, as well as processes, train stakeholders and recognize compliance
23
4.0 CEIV Pharma governance: A partnership model and approach tailored to the needs of the different stakeholders in the value chain with qualified experts
44
5.0 Benefits: A win-win opportunity for all stakeholders 52
6.0 Why IATA: We are a standard setting organization 54
7.0 CEIV Pharma: Update of activities 59
IATA - CEIV Pharma Q1 2015
3
Content
1.0 Introduction: Pharma logistical market growing but air cargo losing market share to other modes of transportation
2.0 Objective: CEIV Pharma is a concerted effort to improve the level of competency, operational and technical preparedness
3.0 Approach and methodology: Validate knowledge, facilities, as well as processes, train stakeholders and recognize compliance
4.0 CEIV Pharma governance: A partnership model and approach tailored to the needs of the different stakeholders in the value chain with qualified experts
5.0 Benefits: A win-win opportunity for all stakeholders
6.0 Why IATA: We are a standard setting organization
7.0 CEIV Pharma: Update of activities
IATA - CEIV Pharma Q1 2015
Q1 2015IATA - CEIV Pharma 4
Industry Cooperation in Air CargoThe Time and Temperature sensitive goods play an important role in air cargo
Security
Safety (e.g.
Dangerous
Goods)
E-Cargo
Special Cargo (ULD, Mail)
Live Animals
Temperature Sensitive Products
� With the healthcare market becoming a key engine of the global economy, pharmaceutical and biomedical industries are facing new challenges in adapting to globalization.
� Speed to market is therefore essential and the healthcare industry is increasingly dependent upon air cargo.
Q1 2015IATA - CEIV Pharma 5
Industry CooperationWhy is air cargo so important?
� Immunization prevents 2.5 million deaths every year.
� Air cargo is critical in flying vaccines to their destination in time to be effective.
Temperature Sensitive Products
Q1 2015IATA - CEIV Pharma 6
Background: Pharmaceutical Product LogisticsGlobal pharma industry will spend $8.36 billion on cold-chain logistics in 2014
8.36
10.28
2013 2017
Temperature management market, 2014-2018In US$ billion
� This market for temperature management services is worth US$8.36 billion currently and is projected to rise to US$10.28 billion by 2018.
� Cold-chain spending for 2014 is divided between an estimated $5.58 billion for logistics services (shipping and storage) and $2.78 billion for tertiary packaging—the insulated and refrigerated containers in which products are transported.
� Nearly 100% of vaccines and 68% of biotech products need to be stored and transported between 2-8°C.
� 48% of diagnostics and 11% of products from large pharmaceutical companies have to be handled similarly.
Source: Pharmaceutical Commerce
Q1 2015IATA - CEIV Pharma 7
Background: Pharmaceutical Product LogisticsTemperature control share of pharma
Temperature management market, 2013-2017In percentage of total business � A big share of pharmaceutical shipments in
the 15-25°C segment are shipped as general cargo.
� A significant part of pharmaceutical shipments requires temperature controlled transport.Of which 75% of shipments require passive cooling solutions, and 20% require active temperature control.
� Active temperature control solutions demand a yield premium due to complex requirements.
� Passive solutions drive volume and are less costly to implement.Source: Seabury, BRU Cargo
Q1 2015IATA - CEIV Pharma 8
Background: Pharmaceutical Product LogisticsThe pharmaceutical industry has relied heavily on the airline industry for its speed and efficiency but air cargo’s share of global pharmaceutical products transport has dropped
Source: Pharmaceutical Commerce
HOWEVER
17
11
2000 2013
Air cargo’s share of global pharmaceutical products transport (in %)
Over the past 10 years, air carriers, handlers and freight forwarders have responded with branded products and services to grab a share of this lucrative and niche market.
Pharma air cargo growth; 2008-2018in %
6
12
2008-2013 2013-2018
Q1 2015IATA - CEIV Pharma 9
Critical Issues Raised by the ShippersIncreasing shift in pharmaceuticals transported by sea due to air cargo challenges
� More than 50% of all temperature excursions occur while the package is in the hands of airlines/airports
� Temperature deviation denature the product, render it worthless and be harmful to the health of the patient
� Products can be lost, scrapped, returned leading to significant costs
� Annual product losses between US$2.5-12.5 billion due to various reasons including temperature excursions during transport and shipping.
Due to a lack of compliance, standardization, accountability and
transparency across the air transport supply chain
The use of air-mode transportation is re-considered unless industry partners
ensure quality services
Q1 2015IATA - CEIV Pharma 10
Air Cargo Industry Concerns and ChallengesTemperature Excursions – Where do they occur?
Low Risk Medium Risk High RiskSource: Expeditors
Q1 2015IATA - CEIV Pharma 11
Air Cargo Industry Concerns and ChallengesNo global certification for handling of pharmaceutical products has led to increased regulations and audits
Regulations for transporting pharmaceutical products vary around the world
� Increasing number of regulations around the world to implement and comply with
� Increasing number of audits
� Airlines, GHAs and forwarders subjected to multiple audits for handling, transportation and distribution (e.g. WHO Appendix 5, EU 92/25/EEC, IATA PCR Chapter 17 & TCR)
� No global certification for handling of pharmaceutical products
Q1 2015IATA - CEIV Pharma 12
Air Cargo Supply Chain ChallengesFrom origin to destination pharmaceutical products can be exposed to different climates
+35°C -10°C
+35°C -10°C
Manufacturers & Shippers
Solutions Providers
AirportGround Handlers
Origin-DestinationAir Carrier
AirportGround Handlers
Distributors & Consignees
Origin Forwarders & Trucking Co’s.
Destination Forwarders & Trucking Co’s.
Road Transport
In-Flight Conditions
Unloading
Airside Transport
HandlingRoad TransportHandling
Loading
Packaging
Q1 2015IATA - CEIV Pharma 13
Critical Issues Raised by the ShippersShippers have difficulties identifying industry stakeholders that meet standards and regulations at origin and destination
14 milestones from start to end.
HOW CAN YOU MANAGE THIS ?
Pick-up
Ground handler BRU
Forwarder X BRU
Shipper
In Out
In Out
Airline BRU – SIN - SYD
Forwarder YSYD
Consignee
InIn Out
SYD in
Ground handler SYD
SIN in outBRU out In Out
Example of Flow from BRU to SYD
Source: BRUCargo
Q1 2015IATA - CEIV Pharma 14
Shippers Expectations in Cold ChainShippers need service providers that maintain product integrity and efficacy during transportation
� Compliance, standardization, accountability and transparency across the supply chain
� Properly trained stakeholders on regulations and standards
� Adequately equipped facilities throughout the supply chain
� Global certification for handling of pharmaceutical cargo
� Common audit format to minimize the disruptions and increase effectiveness
� Ability to easily search and identify stakeholders that meet requirements
15
Content
1.0 Introduction: Pharma logistical market growing but air cargo losing market share to other modes of transportation
2.0 Objective: CEIV Pharma is a concerted effort to improve the level of competency, operational and technical preparedness
3.0 Approach and methodology: Validate knowledge, facilities, as well as processes, train stakeholders and recognize compliance
4.0 CEIV Pharma governance: A partnership model and approach tailored to the needs of the different stakeholders in the value chain with qualified experts
5.0 Benefits: A win-win opportunity for all stakeholders
6.0 Why IATA: We are a standard setting organization
7.0 CEIV Pharma: Update of activities
IATA - CEIV Pharma Q1 2015
Q1 2015IATA - CEIV Pharma 16
Center of Excellence for Independent ValidatorsImprove together to protect and grow our industry
The solution� Develop standards with regulators
� Train industry stakeholders on standards and regulation
� Assess operations against standard check list
� Train independent validators on standards and regulations
� Certify and then register best players on a publicly website
� Get States recognition to ensure audits are valid for all
The Need� … for more safety, security and
efficiency
� … to raise the bar to (re)gain confidence
� … to improve compliance to standards/regulations
� … for independent assessments vs. self-assessments
� … to identify and recognize the best players
� … to harmonize and reduce the number of audits
Q1 2015IATA - CEIV Pharma 17
Center of Excellence for Independent ValidatorsApproach of the CEIV
Regulations and Standards
EXISTING
Standards and Regulations
NEW
Training Training (Recurrent Training)
Validation (Audit) &
Award
Re-Validation (Re-Audit)*
Pre-Validation
Assessment
1 22 33 44 55
� Advocate for globally accepted standards and regulations
� Train instructors on behalf of the airlines, cargo and ground handlers
� Manage the pool of qualified instructors
� Train the Independent Validators to a common standard and validation methodology
� Train operational staff
� Run on-site pre-audits to prepare for validation
� Conduct the validations
� Manage the database of Independent validators
� Manage the database of certified companies
Q1 2015IATA - CEIV Pharma 18
CEIV ACC3 – ExampleAll affected air cargo and mail carriers operating into EU and EEA from third countries (ACC3) must obtain an independent validation of their security program
� IATA has been encouraged by its member airlines and European Regulators to help prepare air carriers for the ACC3 EU Security Validation process.
� Center of Excellence for Independent Validators (CEIV) to train, advice and support industry stakeholders.
� CEIV offers a comprehensive solution in an effort to assist both the aviation industry and its regulators.
OBJECTIVES OF CEIV PRE-ASSESSMENT APPROACH
IATA RESPONSESITUATION
� Provide Pre-validation assessment guidelines.
� Provide standard validation methodology and self-assessment tools.
� Scope of countries and stations that need validation.
� Training courses to prepare validators and airlines.
� EU ACC3 Readiness Workshop.
� Aviation Security Independent Validators Training.
� July 2014 deadline for compliance with new EU regulation is fast approaching.
� Airlines and other entities (non-EU governments) have requested for assistance.
� Some airlines are not prepared.
� Carriers risk the loss of cargo revenues.
Q1 201519
CEIV Pharma targetsWho does CEIV Pharma target?
IATA - CEIV Pharma
Trucking Companies
Freight Forwarders
Distributors
Ground Handlers
Airlines Airports
Q1 2015IATA - CEIV Pharma 20
Proposed Solution for PharmaThe CEIV Pharma aims to ensure a higher and more consistent level of pharmaceutical handling through validations with registered independent validators and instructors
� Manage deployment of validators
� Audit documentation, processes and operations consistently
� Manage quality of validations
� Follow-up
� Award and recognize operators and locations as "CEIV Pharma certified"
� Advocate for globally accepted standards and regulations
� Establish validation checklist with industry
� Establish industry steering group
� Develop training contents
� Develop assessment criteria for instructors and validators exam
� Train instructors, validators and industry stakeholders
� Manage database of certified instructors and validators
� Develop pre-validation assessment toolkit
� Develop a standard validation methodology and assessment tool
� Manage database of validated locations and operators
� Manage re-validation schedule
EXISTING
Standards and Regulations
NEW
Training Training (Recurrent Training)
Validation (Audit) + Award
Re-Certification(Re-Audit)*
Pre-Validation
Assessment
1 22 33 44 55
Q1 2015IATA - CEIV Pharma 21
Objectives of CEIV Pharma ServicesGlobal certification for handling of pharmaceutical products
IATA seeks to improve the handling of pharmaceutical cargo in line with existing regulations and standards:
� Operations will be audited, and certified by IATA against regulations and standards.
� Locations that complete and pass the validation will be awarded and recognized as “CEIV Pharma Certified”.
Such a qualification performed by a neutral organization is required by the shippers (pharmaceutical companies) that require high standards in quality of their products.
Organizations that undergo such a validation would simplify the audits conducted by various pharmaceutical companies and would be in a position to market the receipt of the award.
Pharmaceutical companies have auditors who audit the industry to ensure that relevant regulations are followed and services rendered according to SLAs
Q1 2015IATA - CEIV Pharma 22
Objectives of CEIV Pharma ServicesTo ensure the integrity of the product is maintained throughout the supply chain
� Prevent sanitary issues caused by temperature excursions during transportation of pharmaceuticals.
� Ensure product integrity maintained during transportation until product reaches patient.
� Improve handling of pharmaceuticals and compliant with existing regulations.
� Create a globally consistent and recognized certification that industry can rely on.
� Address industry concerns and provide services to elevate level of competency.
OBJECTIVES
23
Content
1.0 Introduction: Pharma logistical market growing but air cargo losing market share to other modes of transportation
2.0 Objective: CEIV Pharma is a concerted effort to improve the level of competency, operational and technical preparedness
3.0 Approach and methodology: Validate knowledge, facilities, as well as processes, train stakeholders and recognize compliance
4.0 CEIV Pharma governance: A partnership model and approach tailored to the needs of the different stakeholders in the value chain with qualified experts
5.0 Benefits: A win-win opportunity for all stakeholders
6.0 Why IATA: We are a standard setting organization
7.0 CEIV Pharma: Update of activities
IATA - CEIV Pharma Q1 2015
Q1 2015IATA - CEIV Pharma 24
Approach of CEIV Pharma ServicesThe newly established CEIV Pharma offers a comprehensive solution in an effort to assist both the aviation industry and its regulators
� Pre-validation assessment guidelines.
� Standard validation methodology and self-assessment tools: to help airlines and other entities test their state of readiness.
� Training courses to prepare ground handlers, cargo operators and airlines.
Q1 2015IATA - CEIV Pharma 25
Project Approach and MethodologyIATA will certify companies in several steps
Preparation1
Assessment 2
Validation3
� Assemble team
� Prepare project logistics
� Send data and information request
� Send interview request sheet for first visit
� 2 weeks before assessment
� On-site assessment by Independent validator
� Assessment versus minimum IATA Temperature Controlled Audit Checklist
� Comparison against best practice
� Establish findings and offer recommendations for change
� Develop implementation plan and secure resources.
� Drafting of report
� On-site visit by an Independent Validator to review progress made against recommendations during the assessment phase
� Drafting of report
� Min 6-8 weeks after the assessment
5
Certification
Training required for certificationAdditional Training
4
Q1 2015IATA - CEIV Pharma 26
Focus of CEIV PharmaFocus is on assessment and training
On Pharma handling requirements through in-house training at the clients location
Raise awareness
As an integral element within the validation processAssess client
Of the facilities, staff, equipment, processes, practices, and systems using the IATA CEIV Pharma checklists to ensure compliance with documentation and requirements
Conduct on-site observation
For the subsequent validation exercisePrepare client
To assist client in achieving "CEIV Pharma Certified" status and maintaining it following the validation
Capture and convey ‘lessons learned’ and suggest ‘best practice
Highlighting the findings and recommendations that should implement prior to their independent validation
Analyze observations and produce report
Helping creating the independent validation action plan and project plan
Collaborative work
Issues tackled
� Content of manuals and guidelines
� Procedures for Audits
� Procedures for describing packaging systems
� Acceptance checklist quality and operating agreements
� Packaging requirements
� Documentation & labeling
� Acceptance & control
� Facilities and equipment
� Staff training requirements
� Training adequacy and currency
Q1 2015IATA - CEIV Pharma 27
AssessmentReview, compare against best practice, establish findings, offer recommendations for change, identify and mitigate risks, develop implementation plan
Assessment
Criteria applied
� Quality management
� Personnel
� Training
� Documentation
� Infrastructure + equipment
� Operations
� Complaints, returns and counterfeit
� Supplier management
� Self-inspections
� Transportation
� Specific provisions for brokers
Q1 2015IATA - CEIV Pharma 28
AssessmentFocus is on global coverage and universality
IATA GUIDELINES GOOD DISTRIBUTION PRACTICES
E.g. Singapore GDP & GDPMDS or FAGG in Belgium
LOCAL + REGIONAL GUIDELINES
CEIV Pharma:
� encompasses various regulations and standards e.g. EU GDP.
� covers GDP requirements.
� aims at covering international standards and country-specific requirements.
� aims at reducing the number of audits or simplifying them.
Assessment
TCR
GDP
Q1 2015IATA - CEIV Pharma 29
AssessmentCEIV Pharma is looking at a global and consistent GDP+ certification as the “GDP” is very EU centric and not specific to air transport
� CEIV Pharma aims at global and consistent assessments specific to air transport encompassing international standards as well as national regulations.
� Some areas, such as ground and tarmac transportation, aircraft (un)loading are not covered by GDPs.
The goal being to have a network of certified trade-lanes assessed consistently.
Assessment
Local regulations
Q1 2015IATA - CEIV Pharma 30
AssessmentSnapshot of the IATA Standard Check List
Table of Content Example of Questions
Review of progress on action plan
Q1 2015IATA - CEIV Pharma 31
Validation Validate to ensure gaps and recommendations have been implemented
Validation
On-site visit by Independent Validators to review progress made against recommendations during the assessment phase.
Action Packages
Actions
Implementations
• Schedule
• Personnel• Quantitative• Qualitative
At the end of validation decision on whether all requirements have been
fulfilled.
x
Q1 2015IATA - CEIV Pharma 32
Assessment and ValidationDeliverables
Step 1: Assessment Step 2: Validation
� Pharma handling criteria checklist.
� Report covering the findings and recommendations based on the assessment.
� Implementation plan.
� Report and implementation plan will set out assumptions, findings, results, conclusions and recommendations and will specifically:
� Identify critical elements that are not compliant with national and international Regulations and the defined CEIV PharmaHandling criteria (e.g. TCR);
� Outline the impact of non-compliance; and� Identify elements that are inefficient.
� Presentation to Senior Management.
� Progress report to review the progress made against recommendations during the assessment phase.
� Implementation plan update.
� Recommendation to award certification as "CEIV Pharma certified" based on satisfactory compliance of CEIV criteria.
� Presentation of the validation findings to Senior Management.
Q1 2015IATA - CEIV Pharma 33
TrainingAnnex 5: WHO Good Distribution Practices for pharmaceutical products
Section 6. Organization and Management
� Section 6.1 “There should be an adequate organizational structure for each entity defined with the aid of an organizational chart. The responsibility, authority and interrelationships of all personnel should be clearly indicated.”
� Section 6.2 “Duties and responsibilities should be clearly defined and understood by the individual concerned and recorded as written job description. Certain activities may require special attention, such as supervision of performance activities, in accordance with local legislation. At every level of the supply chain, employees should be fully informed and trained in their duties and responsibilities.”
Section 7. Personnel
� Section 7.1 “All personnel involved in distribution activities should be trained and qualified in the requirements of GDP, as applicable.”
� Section 7.2 “Key personnel involved in the distribution of pharmaceutical products should have the ability and experience appropriate to their responsibility for ensuring that pharmaceutical products are distributed property.”
� Section 7.3 “There should be an adequate number of competent personnel involved in all stages of the distribution of pharmaceutical products in order to ensure that quality of the product is maintained.”
Training required forcertification
Additional Training
Q1 2015IATA - CEIV Pharma 34
Training required for certificationSuccessful completion of the 2 mandatory courses for all participants is necessary for obtaining certification
Successful completion of:
� 2 key personal on the “audit” training (5 days);
� 2 key personal distance learning “handling” training; and
� 2 competent personal on the “handling” training (3 days).
Temperature Controlled
Cargo Operations
Risk, Audit and Quality of Temperature Controlled
Cargo
Training required forcertification
Q1 2015IATA - CEIV Pharma 35
Training required for certificationTemperature Controlled Cargo Operations (Classroom, 3 days)
In this course, you will learn the healthcare product distribution in air cargo and the procedures required for handling time and temperature-sensitive shipments
Key topics:
� Overview of the global pharmaceutical industry
� Temperature Management in the supply chain
� Processes & Procedures, acceptance & handling
� Quality Management (overview)
� Packaging Technology
� Standard Operating Procedures (SOP) & Service Level Agreements (SLA)
Temperature Sensitive Cargo Handling
2 competent personnel involved in handling pharmaceutical products activities per station should be trained competent and pass the examination of the “IATA Temperature Controlled Cargo
Handling course” - before the certification.
Training required forcertification
Q1 2015IATA - CEIV Pharma 36
Training required for certificationRisk, Audit, and Quality of Temperature Controlled Cargo (Classroom, 5 days)
Auditing is a powerful management tool in establishing how effectively a company controls the quality of its products and ensures compliance. This hands-on, practical course deals primarily with auditing tools and techniques which are applicable to the pharmaceutical industry.
Key topics: � Quality Management System (QMS)
� Effectiveness of risk management control
� Detection of counterfeits in the supply chain
� IATA Time and Temperature Sensitive Audit Checklist
� Self assessment and validation
� Trigger corrective and preventive measures
Audit and Quality of Temperature Controlled Cargo
2 key personnel per station should be trained and pass the examination of the “IATA Audit, Quality and Risk course” - before the certification.
� Quality Risk Management (QRM) procedures
� Risk assessment, control and management methodology
� Effects of temperature deviation on pharmaceuticals products
Training required forcertification
Q1 2015IATA - CEIV Pharma 37
Training - Before certification
Training required forcertification
Q1 2015IATA - CEIV Pharma 38
Additional TrainingIntroduction to Time and Temperature Pharmaceutical Products
4-6 hours training. Key topics:
� Pharmaceutical products
� Processes & procedures related to job functions
� Identification and labelling
� Effect of temperature on pharmaceutical products
� Avoidance of counterfeits
� Passive and active packing
� Product security
All personnel involved in handling pharmaceutical products activities per station should be trained on “IATA Introduction to Time and Temperature Pharmaceutical Products course“ (or equivalent))
within period of 12 months after the “Certification”
Additional Training
Q1 2015IATA - CEIV Pharma 39
Path to certificationIn a nutshell
Certification!!!
Assessment
Validation
Step 1
Step 3
Step 2Training
Step 4Training (remaining staff)
Q1 2015IATA - CEIV Pharma
Certification Timeline (general approach)
ValidationPreparation Assessment
2-4 days on-site
2-4 days on-site
Training required for certificationAdditional Training
2 weeks
12 months after
certification
2-8 weeks
2-8 weeks
Timeframe depends on results of
assessment.
� Ideally completed before assessment.
� Needs to be completed before validation.
40
Certification
Q1 2015IATA - CEIV Pharma
Award Certificate "CEIV Pharma certified"Example
41
Q1 2015IATA - CEIV Pharma 42
RecertificationRecertification will take place every two years – includes assessment and one refresher training plus a validation if necessary
2 years
����
X
"CEIV Pharma Certified"
Re-assessment
Validation
One RefresherTraining
Close gaps1 - 2 days
1 - 2 days
� e.g. update on new regulations, development on new standards, development of new containers, etc.
����
43
Content
1.0 Introduction: Pharma logistical market growing but air cargo losing market share to other modes of transportation
2.0 Objective: CEIV Pharma is a concerted effort to improve the level of competency, operational and technical preparedness
3.0 Approach and methodology: Validate knowledge, facilities, as well as processes, train stakeholders and recognize compliance
4.0 CEIV Pharma governance: A partnership model and approach tailored to the needs of the different stakeholders in the value chain with qualified experts
5.0 Benefits: A win-win opportunity for all stakeholders
6.0 Why IATA: We are a standard setting organization
7.0 CEIV Pharma: Update of activities
IATA - CEIV Pharma Q1 2015
Q1 2015IATA - CEIV Pharma 44
CEIV Pharma Certification ApproachThere are different approaches to obtain certification
� “Individual” approach: One company decides to get "CEIV Pharma Certified"
� “Community” approach: A group of companies at an airport decide to get "CEIV Pharma Certified" to form a “pharma gateway”
� “Coalition” approach: A group of companies decide to get "CEIV Pharma Certified" at several airports to form several “pharma gateways”
Q1 2015IATA - CEIV Pharma 45
Advocacy governanceStrong emphasis on engaging stakeholder and advocate for endorsement and recognition
� Time and Temperature Task Group –CEIV Pharma Steering Group
Industry
� WHO� FIACA� TIACA
Global
� Approve standards� Approve trainings
� Endorse + recognize standards
� Endorse + recognizetrainingsLocal
� Local stakeholder associations (Shippers, Freight Forwarders, Ground Handlers, Airlines)
� Local BARs
Regional� US GDP � EU
� Global Shippers Forum (GSF) � Cool Chain Association� ICQP
WHO? TASK
Q1 2015IATA - CEIV Pharma 46
Project structure – Who is involved and who can participate?Everyone in the value chain can participate in the certification process
Pharma shippers
Forwarders with pharma focus
Handlers
Truckers
Airlines
TTTF
Regulators
Facilitators
Example (BRUCargo)
Q1 2015IATA - CEIV Pharma 47
Project structureThe project is conducted in close cooperation with relevant stakeholders
Example (BRUCargo)
Q1 2015IATA - CEIV Pharma 48
CEIV Pharma – Who’s is auditing?Qualification and management of independent validators
Qualification Management
� IATA conducts preliminary interview with candidate to pre-qualify candidate for training
� IVs must undergo IATA training
� IVs need to complete trainings within six months
� IV’s can also become instructors but need to undergo the IATA Train-the-trainer course (optional)
� IVs are registered in IATA database and available to complete the assessments and validations
� Coordination of IVs is managed by the IATA team for assessments and validations
� IV cannot have been in a commercial relationship with entity to be validated 12 months prior to the engagement
Q1 2015IATA - CEIV Pharma 49
Independent Validator Qualification and Recruitment Process
Pre-qualification
• Pharma and/or Auditing background;
• Cargo experience; or
• Ground handling experience.
Interview
• Motivation;• Social fit;• Experience;• Expectations.
Pharma Training
• TCC Operations;
• Risk, Audit + Quality Management.
On-the-job assessment
• 1 on-site assessment as a trainee.
Independent Validator
Q1 2015IATA - CEIV Pharma 50
CEIV Pharma – Independent ValidatorsSelection
Bert Elsen Experience with successfully managing all aspects of a large international pharma distribution center. New EU GDP guidelines implementation in 2013.
Andrea Gruber With 15 years of experience in the transport industry first in road then in the air freight industry, Andrea is responsible for the regulations related to the transport of healthcare products.
Celine Crahay With 10 years of industry experience, Celine is a Black Belt Six Sigma with extensive experience in quality management and setting up new Pharmaceutical and Healthcare Centers.
Q1 2015IATA - CEIV Pharma 51
Visibility for CEIV Pharma validated entitiesValidated entities will become visible on IATA’s website
Search Details on a validationResults
52
Content
1.0 Introduction: Pharma logistical market growing but air cargo losing market share to other modes of transportation
2.0 Objective: CEIV Pharma is a concerted effort to improve the level of competency, operational and technical preparedness
3.0 Approach and methodology: Validate knowledge, facilities, as well as processes, train stakeholders and recognize compliance
4.0 CEIV Pharma governance: A partnership model and approach tailored to the needs of the different stakeholders in the value chain with qualified experts
5.0 Benefits: A win-win opportunity for all stakeholders
6.0 Why IATA: We are a standard setting organization
7.0 CEIV Pharma: Update of activities
IATA - CEIV Pharma Q1 2015
Q1 2015IATA - CEIV Pharma 53
CEIV Pharma – Key BenefitsThe CEIV Pharma is a win-win situation for the industry
� Conduct simpler audits of operators� Obtain guarantee that products would be
handled in line with regulations� Experience lower rate of damage and loss
due to temperature excursions� Be able to prepare their products ready for
acceptance
Shippers Airlines, GHAs, Forwarders, Airports
Regulators IATA
� Protect and grow revenues in fastest growing segment of air cargo
� Obtain recognition for operations, facilities and staff after meeting standards
� Experience simpler audits from various organizations
� Promote their best practices to the shipper’s community
� Assured of safety of pharmaceutical products shipped by air
� Access structured and consistent training and registry of independent validators and assessed operators
� Disseminated standards in the industry� Common audit criteria and global
certification� Promote air transport and so limit the modal
shift
54
Content
1.0 Introduction: Pharma logistical market growing but air cargo losing market share to other modes of transportation
2.0 Objective: CEIV Pharma is a concerted effort to improve the level of competency, operational and technical preparedness
3.0 Approach and methodology: Validate knowledge, facilities, as well as processes, train stakeholders and recognize compliance
4.0 CEIV Pharma governance: A partnership model and approach tailored to the needs of the different stakeholders in the value chain with qualified experts
5.0 Benefits: A win-win opportunity for all stakeholders
6.0 Why IATA: We are a standard setting organization
7.0 CEIV Pharma: Update of activities
IATA - CEIV Pharma Q1 2015
Q1 2015IATA - CEIV Pharma 55
IATA a Standard Setting OrganizationSupply Chain Approach
IATACargo Services Conference (CSC)
Live Animal & Perishable Board (LAPB)
Time & Temperature Task Force (TTTF)
ShippersFreight
ForwardersGround
HandlersAirlines Airports
Temperature controlled packaging
Q1 2015IATA - CEIV Pharma 56
IATA a Standard Setting OrganizationDevelopment of Standards – Temperature Sensitive Products
2007
2008 2009
2010
2011
2012
2013
2014Perishable Cargo Regulations (PCR) Industry
standard
PCR New Chapter 17 New T&T
Sensitive
Label
Mandatory
T&T Sensitive
Label
Mandatory
Standard
Checklist
Must be affixed to all shipments booked as T+T sensitive cargo
Provides requirements +
standards
Q1 2015IATA - CEIV Pharma 57
IATA a Standard Setting OrganizationImplementation and Dissemination of Standards
Step 2: DisseminationStep 1: Implementation
Industry feedback driving improvements:
� Need for standardization in the handling of pharmaceutical products in air cargo environment
� Need to enhance partnership and communication
� Need to ensure appropriate training in the supply chain
Support AdoptionSupport Adoption
Prove ConceptProve Concept
Develop Standards
The industry usually asks IATA to address their needs to ensure compliance and quality services
Q1 2015IATA - CEIV Pharma 58
IATA a Standard Setting OrganizationDissemination of Standards in the Industry
59
Content
1.0 Introduction: Pharma logistical market growing but air cargo losing market share to other modes of transportation
2.0 Objective: CEIV Pharma is a concerted effort to improve the level of competency, operational and technical preparedness
3.0 Approach and methodology: Validate knowledge, facilities, as well as processes, train stakeholders and recognize compliance
4.0 CEIV Pharma governance: A partnership model and approach tailored to the needs of the different stakeholders in the value chain with qualified experts
5.0 Benefits: A win-win opportunity for all stakeholders
6.0 Why IATA: We are a standard setting organization
7.0 CEIV Pharma: Update of activities
IATA - CEIV Pharma Q1 2015
Q1 2015IATA - CEIV Pharma 60
CEIV PharmaCertified Pharmaceutical Trade Lanes Development
Certification in Progress
Certification Completed
Locations
5
76
1
1
14
8
1
12 Certification in Discussion
1
Q1 2015IATA - CEIV Pharma 61
CEIV PharmaEuropean Community
Certification in Progress
Certification Completed
Locations
13
7
Q1 2015IATA - CEIV Pharma 62
CEIV PharmaAsian Community
Certification in Progress
Certification Completed
Locations
1
1
Q1 201563
Number of entities assessedIATA will have assessed 36 entities by end of 2015 …and counting
Source: IATA
1
36
Area 3 Area 2
Entities assessed 2013 - 2015; in no. of entities assessed
Entities assessed / region in 2013 -2015; in no. of entities assessed
Area 1: The AmericasArea 2: Europe / CISArea 3: Asia / PacificArea 4: MENA / AfricaArea 5: North Asia
Total (2013-2015)
1
14
23
2013 2014 2015
1 15 37
IATA - CEIV Pharma
Q1 201564
Number of entities assessed> 25 entities certified by the end of the year… and counting
1
18
Area 3 Area 2
Entities certified by 2015; in no. of entities certified
Entities certified / region by 2015; in no. of entities certified
Area 1: The AmericasArea 2: Europe / CISArea 3: Asia / PacificArea 4: MENA / AfricaArea 5: North Asia
Source: IATA
6
28
2014 2015
6 34
Total
Minimum no. of entities that will finalize certification
IATA - CEIV Pharma
Q1 201565
Number of entities certified19 entities will have been certified between SEP/2014 and JUL/2015
Entities certified by June 2015; in no. of entities certified BY TYPE
Total (by June 2015)
6 19
Source: IATA
01
45
2
10
0
3
2014 2015
Airlines
Ground Handler
Freight Forwarder
Trucking+1
+1
+8
+3
IATA - CEIV Pharma
Q1 201566
Number of entities assessedIATA will have conducted assessments at 6 airports between SEP/2014 and MAR/2015
1
16
Area 3 Area 2
Entities assessed 2013 - 2015; in no. of entities assessed
Entities assessed / region in 2014; in no. of entities assessed
Area 1: The AmericasArea 2: Europe / CISArea 3: Asia / PacificArea 4: MENA / AfricaArea 5: North Asia
Source: IATA
1
4
2
2013 2014 2015
1 5 7
Total
IATA - CEIV Pharma
Q1 2015IATA - CEIV Pharma 67
SATS Coolport ProjectPilot project conducted between November 2013 and February 2014, trainings still on-going
Q1 2015IATA - CEIV Pharma 68
SATS Coolport Pilot ProjectHandover ceremony in February 2014
Q1 2015IATA - CEIV Pharma 69
SATS Recertification ProjectCeremony in November 2014
Q1 201570
Community ApproachBRU Airport Project –started in Aug. 2014 and end date planned in Jun. 2014
� Regulators engaged (FAGG, Customs)
� Shippers engaged and
� All trainings conducted
� 11 company assessments completed in two waves (AUG/SEP/2014 and NOV/2014)
� 7 companies validated and certified
� Remaining validations in MAY-JUN/2015
� Second wave under preparation
IATA - CEIV Pharma
Q1 201571
Individual ApproachBCUBE Project –started in Nov. 2014 and end date planned in Jun. 2014
� Shippers engaged
� Mandatory Trainings completed
� FCO, MXP and LIN assessed in November and beginning of December
� Validations start in June once construction is finished
VLE
IATA - CEIV Pharma
Q1 201572
Individual ApproachCAL and LACHS Project –started in March and end date planned in Jun. 2015
Liege is the very center of gravity for CAL activities
� Airline and its proprietary ground handling company LACHS
� Shippers engaged
� Mandatory Trainings in April 2015
� Assessment of airline and facility in April 2015
� Validations start in June 2015
� LACHS owns a state-of-the-art facility including:� Temperature controlled warehouse� 16,000sqm of space� The largest capacity high loader (52 tons) in
Europe � High security clearance
IATA - CEIV Pharma
Q1 201573
Individual ApproachALHA Group –started in March and end date planned in Jun. 2015
� Mandatory Trainings in March and April 2015
� Assessment of FCO facility in April 2015
� Assessment of MXP facility in May 2015
� Validations start in June 2015
IATA - CEIV Pharma
Q1 201574
Individual ApproachCargologic –started in March and end date planned in Jun. 2015
� Mandatory Trainings in April and May
� Assessment of ZRH facility in May
IATA - CEIV Pharma
Q1 2015IATA - CEIV Pharma 75
Advocacy GovernanceSupport from Shippers
Spain
Belgium
Q1 2015IATA - CEIV Pharma 76
Testimonials
Holistic/community approach is the competitive advantage vs other program. The fact that the program is industry specific is a key differentiator vs GDP.
Frank van Gelder, Adelantex
The program helps reducing the scope of shipper audits. CEIV is good sales tool to promote our business to clients: it ensures a robust cold chain in every step in the supply chain through the airport for handling the pharma shipper’ temperature sensitive products.
Eric Veeckmans, UTi Brussels
Q1 2015IATA - CEIV Pharma 77
Endorsement from Belgian RegulatorOn November 25, 2014, the Belgian Regulator FAGG – AFMPS formally endorsed the CEIV Pharma Program
The Belgian regulator, the federal agency for medicines and health
products (famhp) is endorsing the IATA CEIV program. It has been
involved in the BRUcargo community certification from the start of
the program. Famhp Inspectors have also participated in the
training sessions and workshops.
Josiane Van der Elst, Director General DG Inspection FAGG says
“Although this type of IATA certification is not an authority-issued
regulatory document, initiatives of structured control on transport are
important and welcomed by famhp DG INSPECTION. The IATA
certification gives more confidence that pharmaceutical air freight
shipments are handled in accordance with EU GDP guidelines”.
fagg – afmps, November 25, 2014
THANK YOU
For further information, contact:
Ronald SCHAEFERProject Lead, Center of Excellence (CEIV) Pharmaceutical Logistics
Miami, FL
Email: [email protected]: + 1 305 779 9873
Mob: + 1 305 586 4666